Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Channel Therapeutics Corp...

    NYSE: PTHS · Real-Time Price · USD
    22.73
    0.14 (0.62%)
    At close: Aug 26, 2025, 1:16 PM

    Channel Therapeutics Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024
    Revenue
    		 n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a n/a
    Operating Income
    		 -3.23M -1.83M -1.83M -2.05M -1.76M -1.93M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -3.45M -1.97M -1.93M -1.69M -1.77M -2.56M
    Net Income
    		 -3.45M -1.97M -1.93M -1.69M -1.77M -2.56M
    Selling & General & Admin
    		 2.72M 1.64M 1.54M 1.63M 1.75M 1.47M
    Research & Development
    		 514.81K 194.3K 285.24K 414.64K 12.96K 466.61K
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 3.23M 1.83M 1.83M 2.05M 1.76M 1.93M
    Interest Expense
    		 218.52K 133.63K 107.97K 39.02K 11.06K 628.35K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 3.23M 1.83M 1.83M 2.05M 1.76M 1.93M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 640.52K 612.79K n/a 579.23K 577.37K 469.1K
    Shares Outstanding (Diluted)
    		 640.52K 612.79K n/a 579.23K 577.37K 469.1K
    EPS (Basic)
    		 -5.38 -3.2 n/a -2.9 -3.07 -5.5
    EPS (Diluted)
    		 -5.38 -3.2 n/a -2.9 -3.07 -5.5
    EBITDA
    		 -3.23M -1.83M -1.82M -1.66M -1.76M -1.93M
    EBIT
    		 -3.23M -1.83M -1.82M -1.66M -1.76M -1.93M
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a

    Add to Watchlist